Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India.

Authors :: Kaur A
Gandra S
Gupta P
Mehta Y
Laxminarayan R
Sengupta S
Source :: American journal of infection control [Am J Infect Control] 2017 Nov 01; Vol. 45 (11), pp. 1289-1291. Date of Electronic Publication: 2017 Aug 12.
Publication Year :: 2017
Abstract: In this study, we retrospectively evaluated clinical outcomes of 75 patients with dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections over a 5-year period in a single tertiary care hospital in India. We observed a high in-hospital mortality rate of 69.3%. Our findings indicate the urgent need for new antibiotics to treat these infections.<br /> (Copyright © 2017 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.)

Subjects :: Bacteremia drug therapy
Carbapenem-Resistant Enterobacteriaceae drug effects
Drug Resistance, Multiple, Bacterial
Female
Humans
India epidemiology
Klebsiella Infections microbiology
Male
Microbial Sensitivity Tests
Middle Aged
Retrospective Studies
Treatment Outcome
Anti-Bacterial Agents therapeutic use
Bacteremia microbiology
Carbapenems therapeutic use
Colistin therapeutic use
Klebsiella Infections drug therapy
Klebsiella pneumoniae drug effects

Full Text Access

Tools